NO884406L - Fremgangsmaate for fremstilling av heterocykliske spiroforbindelser. - Google Patents
Fremgangsmaate for fremstilling av heterocykliske spiroforbindelser.Info
- Publication number
- NO884406L NO884406L NO88884406A NO884406A NO884406L NO 884406 L NO884406 L NO 884406L NO 88884406 A NO88884406 A NO 88884406A NO 884406 A NO884406 A NO 884406A NO 884406 L NO884406 L NO 884406L
- Authority
- NO
- Norway
- Prior art keywords
- group
- formula
- atom
- alkyl
- chem
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25210487 | 1987-10-05 | ||
| JP28629787 | 1987-11-12 | ||
| JP8432788 | 1988-04-05 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO884406D0 NO884406D0 (no) | 1988-10-04 |
| NO884406L true NO884406L (no) | 1989-04-06 |
| NO171109B NO171109B (no) | 1992-10-19 |
| NO171109C NO171109C (no) | 1993-01-27 |
Family
ID=27304516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO884406A NO171109C (no) | 1987-10-05 | 1988-10-04 | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske spiroforbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US4940795A (no) |
| EP (1) | EP0311313B1 (no) |
| JP (1) | JPH0236183A (no) |
| KR (1) | KR970007947B1 (no) |
| CN (1) | CN1036653C (no) |
| AT (1) | ATE122353T1 (no) |
| AU (1) | AU621559B2 (no) |
| CA (1) | CA1337817C (no) |
| DE (1) | DE3853758T2 (no) |
| DK (1) | DK554288A (no) |
| ES (1) | ES2074441T3 (no) |
| GR (1) | GR3016995T3 (no) |
| HU (1) | HU211687A9 (no) |
| NO (1) | NO171109C (no) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0311313B1 (en) * | 1987-10-05 | 1995-05-10 | Yamanouchi Pharmaceutical Co. Ltd. | Heterocyclic spiro compounds and their preparation |
| US5412096A (en) * | 1987-10-05 | 1995-05-02 | Yamanouchi Pharmaceutical Co., Ltd. | Hydrochloride salts of heterocyclic spiro compounds |
| US5594000A (en) * | 1989-06-21 | 1997-01-14 | Astra Ab | Spirofurane derivatives |
| US5075317A (en) * | 1989-06-21 | 1991-12-24 | Fisons Corporation | Spirofurane derivatives |
| US5407938A (en) * | 1990-04-10 | 1995-04-18 | Israel Institute For Biological Research | Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines) |
| US5852029A (en) * | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
| US5073560A (en) * | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
| IE914238A1 (en) * | 1990-12-19 | 1992-07-01 | Fisons Corp | Novel spirofurane derivatives |
| ES2118814T3 (es) * | 1991-05-15 | 1998-10-01 | Yamanouchi Pharma Co Ltd | L-tartrato de (-)-(s)-2,8-dimetil-3-metilen-1-oxa-8-azaspiro(4,5)decano. |
| DE69412067T2 (de) * | 1993-01-28 | 1999-03-25 | Merck & Co Inc | Substituierte spiro-azaringen als tachykinine rezeptor antagonisten |
| ATE166650T1 (de) * | 1993-03-04 | 1998-06-15 | Pfizer | Spiroazacyclischderivate als substanz p antagonisten |
| JP2983141B2 (ja) * | 1993-10-06 | 1999-11-29 | 株式会社三和化学研究所 | 新規化合物及び該化合物を有効成分とする脳機能改善剤 |
| CA2289578A1 (en) | 1997-05-30 | 1998-12-03 | Neurosearch A/S | Spiro-quinuclidine derivatives, their preparation and use |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
| WO2001011968A2 (en) * | 1999-08-13 | 2001-02-22 | Aventis Cropscience Gmbh | Heterocyclic spiro compounds as pesticides |
| JP2003530432A (ja) * | 2000-04-12 | 2003-10-14 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | 神経変性疾患の治療 |
| JP2003063964A (ja) * | 2001-08-28 | 2003-03-05 | Senju Pharmaceut Co Ltd | ドライアイまたはドライアイを伴なう疾病の予防治療剤 |
| US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
| US20090082381A1 (en) * | 2005-07-26 | 2009-03-26 | Akiharu Isowaki | Percutaneously Absorbable Ophthalmic Preparation |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス，インコーポレイティド | Ｐｄｅ阻害による神経新生の調節 |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| JP2009536667A (ja) * | 2006-05-09 | 2009-10-15 | ブレインセルス，インコーポレイティド | ５ｈｔ受容体介在性の神経新生 |
| ITMI20061279A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche |
| KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008036678A2 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| WO2008036846A2 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| ES2521494T3 (es) | 2007-04-02 | 2014-11-12 | Parkinson's Institute | Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos |
| US8673931B2 (en) * | 2009-01-26 | 2014-03-18 | Abraham Fisher | Bicyclic heterocyclic spiro compounds |
| US9034891B2 (en) | 2009-01-26 | 2015-05-19 | Israel Institute For Biological Research | Bicyclic heterocyclic spiro compounds |
| WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| ES2716049T3 (es) | 2012-07-13 | 2019-06-07 | Pain Therapeutics Inc | Un método para inhibir la fosforilación de tau |
| US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
| CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
| CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| CN115124545B (zh) * | 2022-08-31 | 2023-01-03 | 南京远淑医药科技有限公司 | 一种促性腺激素释放激素受体拮抗剂中间体的合成方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3305556A (en) * | 1962-11-23 | 1967-02-21 | Pfizer & Co C | Novel hypoglycemic agents |
| NL124853C (no) * | 1963-07-19 | |||
| SU335944A1 (ru) * | 1970-12-15 | 1976-01-25 | Научно-исследовательский институт химии Саратовского государственного университета им.Н.Г.Чернышевского | Способ получени соединений р да 1-окса6-азаспиро(4,4)нонана |
| US3784551A (en) * | 1971-07-08 | 1974-01-08 | Yoshitomi Pharmaceutical | 2-oxo-1,4-dioxa-8-azaspiro (4.5) decanes and related compounds |
| GB1301254A (no) * | 1971-07-08 | 1972-12-29 | ||
| US3839273A (en) * | 1971-11-13 | 1974-10-01 | Sankyo Co | N-substituted piperidine derivatives, process for preparing the same and their use as stabilizers |
| SU434735A1 (ru) * | 1972-03-01 | 1975-12-15 | Научно-исследовательский институт химии Саратовского государственного университета им.Н.Г.Чернышевского | Способ получени 7-метил-(или 2,7диметил)-2-метокси- -пропионитрил1-окса-6-азаспиро-(4,4)-нонана |
| SU465399A1 (ru) * | 1973-07-19 | 1975-03-30 | Научно-исследовательский институт химии при Саратовском государственном университете им.Н.Г.Чернышевского | Способ получени натриевых солей 2-метокси- -карбоксиэтил-1-окса6-азаспиро-(4,4)-нонана |
| IL48452A (en) * | 1975-11-11 | 1979-07-25 | Purdue Frederick Co | Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them |
| US4321379A (en) * | 1981-01-28 | 1982-03-23 | American Cyanamid Company | 4-Aryl-1-oxa-8-azaspiro[4,5]dec-3-en-2-ones |
| SU1002294A1 (ru) * | 1981-08-14 | 1983-03-07 | Ордена Трудового Красного Знамени Институт Тонкой Органической Химии Им.А.Л.Мнджояна | 2,2-Диалкил-3-тиа-8-азаспиро/5,5/ундеканы |
| EP0189370A3 (de) * | 1985-01-16 | 1988-01-27 | Sandoz Ag | Spiro-dioxolane, -dithiolane und -oxothiolane |
| US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
| US4981858A (en) * | 1987-08-13 | 1991-01-01 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Optical isomers |
| EP0311313B1 (en) * | 1987-10-05 | 1995-05-10 | Yamanouchi Pharmaceutical Co. Ltd. | Heterocyclic spiro compounds and their preparation |
| US5073560A (en) * | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
-
1988
- 1988-09-30 EP EP88309095A patent/EP0311313B1/en not_active Expired - Lifetime
- 1988-09-30 DE DE3853758T patent/DE3853758T2/de not_active Expired - Lifetime
- 1988-09-30 AT AT88309095T patent/ATE122353T1/de not_active IP Right Cessation
- 1988-09-30 ES ES88309095T patent/ES2074441T3/es not_active Expired - Lifetime
- 1988-10-03 CA CA000579193A patent/CA1337817C/en not_active Expired - Fee Related
- 1988-10-04 JP JP63251489A patent/JPH0236183A/ja active Granted
- 1988-10-04 DK DK554288A patent/DK554288A/da not_active Application Discontinuation
- 1988-10-04 NO NO884406A patent/NO171109C/no unknown
- 1988-10-05 CN CN88109138A patent/CN1036653C/zh not_active Expired - Fee Related
- 1988-10-05 US US07/254,375 patent/US4940795A/en not_active Ceased
- 1988-10-05 AU AU23449/88A patent/AU621559B2/en not_active Ceased
- 1988-10-05 KR KR1019880012963A patent/KR970007947B1/ko not_active IP Right Cessation
-
1990
- 1990-01-25 US US07/470,091 patent/US4996210A/en not_active Expired - Fee Related
- 1990-01-25 US US07/470,093 patent/US5041549A/en not_active Expired - Fee Related
-
1992
- 1992-07-07 US US07/909,639 patent/USRE34653E/en not_active Expired - Lifetime
-
1995
- 1995-06-30 HU HU95P/P00638P patent/HU211687A9/hu unknown
- 1995-08-02 GR GR950402111T patent/GR3016995T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| USRE34653E (en) | 1994-07-05 |
| CN1036653C (zh) | 1997-12-10 |
| JPH0236183A (ja) | 1990-02-06 |
| US4996210A (en) | 1991-02-26 |
| AU2344988A (en) | 1989-04-06 |
| JPH0544948B2 (no) | 1993-07-07 |
| EP0311313A3 (en) | 1990-12-05 |
| ES2074441T3 (es) | 1995-09-16 |
| DK554288D0 (da) | 1988-10-04 |
| DE3853758D1 (de) | 1995-06-14 |
| AU621559B2 (en) | 1992-03-19 |
| DE3853758T2 (de) | 1995-09-07 |
| US5041549A (en) | 1991-08-20 |
| NO171109B (no) | 1992-10-19 |
| KR890006649A (ko) | 1989-06-15 |
| KR970007947B1 (ko) | 1997-05-19 |
| CN1033629A (zh) | 1989-07-05 |
| ATE122353T1 (de) | 1995-05-15 |
| NO171109C (no) | 1993-01-27 |
| EP0311313A2 (en) | 1989-04-12 |
| CA1337817C (en) | 1995-12-26 |
| US4940795A (en) | 1990-07-10 |
| NO884406D0 (no) | 1988-10-04 |
| EP0311313B1 (en) | 1995-05-10 |
| HU211687A9 (en) | 1995-12-28 |
| DK554288A (da) | 1989-05-26 |
| GR3016995T3 (en) | 1995-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO884406D0 (no) | Fremgangsmaate for fremstilling av heterocykliske spiroforbindelser. | |
| ES2071681T3 (es) | Compuestos macrociclicos. | |
| IE872615L (en) | TRIAZOLO (1,5-c) PYRIMIDINE DERIVATIVES | |
| SE8501421L (sv) | 1-(hydroximetyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- eller -tiazino(4,3-a)isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
| IL76175A0 (en) | Tricyclic oxindole derivatives and pharmaceutical compositions containing them | |
| DE69129165D1 (de) | Prozess zur Darstellung von Lactamderivaten | |
| FR2681865B1 (fr) | Nouveaux derives de la benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent. | |
| NZ228803A (en) | Sulphonanilides and anti-hypertensive compositions | |
| AU546679B2 (en) | Hydrogenated 1,4 thiazepine (thiazine) dione derivatives | |
| NZ238238A (en) | 5h,10h-pyrido(3,4-b)pyrrolo(1,2-e)(1,4,5)oxadiazepine derivatives and pharmaceutical compositions thereof having analgesic activity | |
| ZA905407B (en) | Pyrrolo(2,1-b)thiozle derivatives | |
| DE3883434D1 (de) | Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen. | |
| HUP9801716A1 (hu) | 5H,10H-Imidazo[1,2-a]indeno[1,2-e]pirazin-4-on-származékok, eljárás előállításukra,az ezeket tartalmazó gyógyszerkészítmények és a vegyületek intermedierjei | |
| ATE29885T1 (de) | 3-(2-(mono- und dialkylamino)propyl)-1,2,3,4tetrahydro-5h-(1)benzopyrano(3,4-c)pyridin-5-on und derivate dieser verbindungen, verfahren zu ihrer herstellung und solche verbindungen enthaltende pharmazeutische zusammensetzungen. |